Genomics 10x Guides Q4 and Fiscal Year Higher Than Consensus (TXG:NASDAQ)


3rd to 4th quarter symbol. Wooden cubes turned and words changed

Dmitri Dzemidovich

  • 10x Genomics (NASDAQ:TXG) wait Q4 revenue of ~$165M, representing 9% Q/Q growth and 10% YoY decline; the number remains above the consensus estimates of 153.51 million dollars.
  • The highest year-on-year growth is estimated to come from the services segment, while instruments



Source link

  • Related Posts

    The stock market thinks the Iran war will last 4 weeks, according to Goldman’s head of oil research

    After a major military campaign by the US and Israel against Iran that resulted in the death of Supreme Leader Ayatollah Ali Khamenei, oil markets around the world experienced an…

    Stanley Black & Decker to cut 300 jobs and close Connecticut tape measure plant

    Bianco Research President and Strategist Jim Bianco and The Expert Press CEO Dave Maney break down the pressures U.S. CEOs face in the job market. Stanley Black & Decker said…

    Leave a Reply

    Your email address will not be published. Required fields are marked *